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Employer attitudes towards general health checks and HIV testing in the workplace 
 
Abstract 
 
Objective: There is a need to increase HIV testing rates in the UK. One approach is to 
increase access to testing through general health checks (GHCs) in the workplace. However, 
it is unclear whether GHCs are routinely offered by organisations, and employer perceptions 
of HIV testing are largely unknown.  
Study Design: Online survey to assess attitudes towards and provision of general health 
checks and HIV testing in the workplace.  
Methods: 98 employers from 25 job sectors completed an online survey. Employers were 61 
SME, 37 large organisations; 86% employing mobile workers, 77.6% employing migrant 
workers and 51.7% of employees were male workers. Items included employer attitudes 
around workplace health, GHC provision, content and delivery, and attitudes towards 
workplace HIV testing including perceived benefits and barriers to HIV testing. 
Results: Only 1 company offered opt-in workplace HIV testing. 78 companies (80%) did not 
provide any form of workplace GHC for employees. Decisions about health check provisions 
were not commonly informed by staff consultation (n=6) or national guidelines (n=4).  100% 
of companies (n=98) reported at least one benefit of HIV testing and 68 (69%) believed that 
HIV testing should be offered in the workplace. Perceived barriers to HIV testing in the 
workplace were: [a] not having enough knowledge about HIV and testing; [b] not having 
trained staff to undertake HIV testing; and, [c] not knowing how to access HIV testing kits. 
56 companies (57.14%) would consider HIV testing as a future provision at their 
organisation. 67 companies (68.37%) would like further guidance on workplace HIV testing.  
Conclusions: Few employers offer general health testing for employees, and opt-in 
workplace HIV testing is exceptionally rare, despite positive attitudes towards it. There is a 
need to provide evidence-based guidance and support for employers around HIV testing in 
the workplace. 
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Highlights  
 Opt-in HIV testing is rarely offered in the workplace setting 
 Employers are positive towards workplace general health testing with opt-in HIV tests 
 Barriers include lack of HIV-related knowledge and access to testing resources 
 Employer guidance and support is required around workplace HIV testing  
 Normalising HIV testing at work may increase access to testing in at-risk groups  
 
Introduction 
Key groups affected by HIV/AIDS in the UK are migrant populations (especially from sub-
Saharan Africa) and men who have sex with men (MSM).1 Late diagnosis of HIV is found 
particularly amongst migrants from Africa, and is associated with increased risk of mortality 
and morbidity, onward HIV transmission, and high healthcare costs.1-6 There is an urgent 
need to expand HIV testing beyond specialised services in order to increase uptake and 
reach.7-10  
The workplace is advocated as an ideal setting for promoting health.11-13 Workplace health 
programmes are aimed at improving the mental and physical health and wellbeing of people 
at work, although they are strategically important for businesses and the economy.14, 15 
These initiatives may involve health education and awareness raising, preventative lifestyle 
interventions (e.g. physical activity, weight management, smoking cessation) and health 
screening. Some organisations offer general health checks (GHCs) to their employees, either 
in isolation, or as part of a more coordinated workplace health programme. GHCs generally 
target common risk factors for chronic disease, including weight, body mass index (BMI), 
fitness testing or blood pressure. These health checks differ to occupational health 
surveillance where test results have health and safety connotations and may be required by 
law for employees exposed or potentially exposed to occupational hazards. By contrast, 
GHCs are promoted to employees as optional check-ups of their overall health, in order that 
employees can determine their risk of developing certain health problems.   
Workplace GHCs may be as a useful mechanism for assessing individual health risks, 
increasing health awareness, and advocating healthier lifestyle behaviours among 
employees. Although the evidence for longer-term behavioural changes resulting from GHCs 
is limited16, employees value the investment of the organisation in their health and 
wellbeing and they are accessed by individuals with diverse socio-demographic 
characteristics and occupational roles.17 Indeed, the workplace may be a useful platform for 
reaching individuals reporting risk factors for disease,17 and other ‘high-risk’ or vulnerable 
groups including those with limited access to primary health care or subcultural inertia with 
respect to anticipatory healthcare.18  
Workplace HIV testing has been utilised in regions of the world where HIV prevalence is 
particularly high (especially sub-Saharan Africa) and within key sectors (such as mining, 
military, police, transport and healthcare organisations) that employ population groups that 
may be particularly vulnerable to HIV.19-21 Most programmes provide HIV testing as a 
distinct service that needs to be specifically sought out, rather than integrating it with other 
health tests.22-26 Evidence on the effectiveness of such programmes is extremely limited, but 
there is ongoing concern over lower than expected uptake of testing.27-29 Workplace HIV 
testing programmes have uncovered a number of challenges from the perspective of 
workers (primarily fear of stigma and discrimination) and employers (primarily limited 
recognition of their potential role in HIV prevention and reluctance to bear the costs).28, 30   
In the UK, workplace HIV testing (with a particular focus on migrant workers) has recently 
been found to be feasible, and acceptability among employees for ‘normalising’ testing 
within a wider GHC is overwhelmingly high (92%).31 Embedding HIV testing within workplace 
GHCs may therefore serve as a useful approach for increasing access to HIV testing and 
ultimately increase testing rates in the UK. However, little is known about the current 
provision of GHCs and whether this differs by job sector or organisational size. There is 
limited evidence around the nature of health checks being offered in UK workplaces; 
whether and how they are offered, what they include and whether HIV testing is already 
part of this provision. Finally, a better understanding of employer’s views towards 
workplace HIV testing including perceived benefits and caveats will inform future delivery 
strategies.  
The overall aim of this study was to determine whether GHCs are routinely offered by 
organisations, and to ascertain employer perceptions of workplace HIV testing. The main 
objectives were to ascertain: [1] the proportion of organisations offering opt-in workplace 
HIV testing; [2] current provision of GHCs; [3] perceived benefits and caveats of workplace 
HIV testing; [4] interest in future delivery of workplace HIV testing; [5] organisational 
support needs for testing.  
 
Methods 
Ethical approval for the study was received from the University of [insert after blind peer 
review] Faculty of Medicine and Health Sciences Ethics Committee on 20th March 2017 
[Ref: LT12042016]. An online survey was created using Bristol Online Survey (BOS; 
https://www.onlinesurveys.ac.uk), a platform selected due to compliance with all UK data 
protection laws and the potential for access control, encryption and account security. The 
survey included nine items on organisation profiles, seven items on employer attitudes 
around workplace health, and 16 items on company provision of GHCs, their content and 
the nature of their delivery. There were 13 items on employer attitudes towards workplace 
HIV testing (including benefits and barriers to HIV testing, and requirements for future 
guidance for employers around HIV testing). No pre-existing survey was available and so the 
survey content was developed by the research team and reviewed by an panel of 10 
individuals with specific expertise in workplace health, and/or HIV testing. Expert review 
was undertaken to ensure the relevance of items to the study aims, and since it is 
recommended for identifying question problems that result in lower survey data quality.32 
An invitation message containing a link to the survey was circulated by email (or twitter) to 
employers through a list of top 200 regional organisations (East Midlands), and three UK-
online professional networks (1 East Midlands; 2 UK-wide) in May-June 2017. Since the 
intention was to scope provision and attitudes across sectors and types of organisation, no 
organisations were deemed ineligible for the study. We requested responses from 
individuals on behalf of their organisations (including company directors or senior 
management, human resource managers, or occupational health specialists). Study 
information was provided online, and anonymous completion of the survey was taken to be 
informed consent. The invitation was re-circulated to the same networks as a reminder after 
a period of four weeks. Data were analysed using IBM SPSS Statistics Version 24. Analysis 
included descriptive statistics, Pearson’s chi-square or Fisher Exact Test. The Fisher Exact 
test results were reported if the 20% or more cells had expected cell count less than 5. 
  
Results 
Representatives of 98 organisations from 25 job sectors completed the online survey (see 
Figure 1). Company and employee profiles are described in Table 1. Seventy-six 
representatives (77.6%) reported that their organisations employed migrant workers. Of 
these, 39 reported the proportion of migrant workers in their organisations, which ranged 
from 1-76% (mean = 19.27%; SD =20.88%).  
[insert Figure 1 in colour, and Table 1 about here] 
In the 76 organisations who reported employing migrant workers, these workers reportedly 
came from Sub-Saharan Africa (n=10 organisations, 13.2%); Eastern Europe (n=8 
organisations, 10.5%); other parts of Europe (n=7 organisations, 9.2%); Asia and Pacific (n=5 
organisations, 6.6%); North Africa and Middle East (n=1 organisation, 1.3%); North America, 
South America and the Caribbean (n=1 organisation, 1.3%); and other regions of the world 
(n=2 organisations, 2.6%). However, half of the representatives from organisations 
employing migrants indicated that one region did not predominate, and that migrant 
workers came from very diverse regions (n=42 organisations, 55.3%). Eight-six 
representatives (87%) reported that their organisations employed mobile workers, and 82 
(79.6%) of these specified the proportion of migrant workers in their organisations.  
Details of representative’s attitudes around workplace health and company provision of 
workplace GHCs are summarised in Table 2. 
[insert Table 2 about here] 
Almost all of the 98 company representatives believed that promoting employee health and 
wellbeing is important, irrespective of the size or type of organisation (n=95; 96.9%). Over 
one-third of the company representatives felt that their organisation was not well-equipped 
to support an employee disclosing a long-term condition (n=35; 35.7%). There was a 
significant difference between organisations, with micro and small organisations being 
significantly less well equipped to provide support for employees disclosing long-term 
conditions than medium or large organisations (Pearson Chi-square 34.85, df 3, p<0.001, 
Carmer’s V 0.60). Less than half of responding organisations had employee health and 
wellbeing as part of their organisational strategy (n=41; 41.8%), and those that did were 
significantly more likely to be larger organisations (n=28; 75.7%). Less than one quarter of 
the organisations had offered GHCs for their employees within the last year (n=22; 22.4%) 
(and these were significantly more likely to be larger organisations: n=18; 48.6%), although 
almost half (n=45; 45.9%) indicated that they would or might consider providing them in the 
future. Only one third of the companies invited charities into their organisation to raise 
employee awareness about health and wellbeing (n=33; 33.7%), and these were more likely 
to be larger organisations (n=24; 64.6%). 
Seventy-six companies (77.5%) did not offer any form of GHC (56 SMEs, 20 Large). 
Companies that did not offer GHCs reported employing migrant workers (n=56, 73.7%; 
57.1% of workforce) and mobile workers (n=62, 81.5%; 62.3% of workforce). There were no 
significant differences in whether organisations offered GHCs or not, between job sectors. 
Around one-fifth of responding company representatives (n=20/98) offered some form of 
GHC during the employment at the workplace (excluding job-related occupational health 
surveillance, n=2). These were relatively brief, and most commonly lasted between 15-30 
minutes (n=10, 50%) or less than 15 minutes (n=8, 40%). At all the companies offering GHCs, 
these were available to all permanent employees. The majority of the companies offering 
health checks included employees on temporary contracts (n=18, 90%), and two-thirds of 
the companies made tests accessible to external contractors or agency workers (n=13, 65%). 
Testing location varied, with companies offering the GHCs at their occupational health 
department (n=9, 45%), in another private room (n=13, 65%), or in open areas such as 
restaurants or common rooms (n=8, 40%). 
General Health Checks (GHCs) 
Amongst the 20 companies that offered some form of GHC, the checks predominantly 
included measures of weight (85%), body mass index (80%), resting heart rate (45%), blood 
glucose level (55%), blood cholesterol level (55%) and stress (25%). A small number of 
organisations offered additional testing such as blood pressure, body/ visceral fat, hearing, 
eye, skinfold thickness, waist-to-hip ratio, lung function or spirometry if offered by voluntary 
or third sector organisations. The GHCs very rarely included other forms of health testing 
such as strength and aerobic fitness tests, bone density, or tests for Tuberculosis (TB), HIV 
and Hepatitis C. Testing for Tuberculosis (TB), HIV and Hepatitis C was provided only by one 
respondent, a single large organisation from within the health sector, and this was offered 
as part of a GHC. All organisations offering GHC provided test results and some form of 
tailored advice for attendees (n=20, 100%), which may be verbal (n=17, 85%), written (n=14, 
70%) or both. Most of the organisations provided information for employees to take away in 
the form of written feedback or other resources (n=17, 85%). None of the companies 
offered results in braille and only two companies (10%) offered written results in a language 
other than English. 
In this sample of 20 organisations offering GHCs, these were most commonly offered 1-2 
times per year (n=13, 65%), with a small number of organisations offering them more 
frequently, or on demand from employees (n=7, 35%). Decisions about the content of 
workplace GHCs were predominantly based on direct approach from external organisations 
with offers of particular testing provision (n=5), or alternatively, decisions were made 
through discussion about the content within internal team meetings (n=3) or both of these 
approaches (n=8). Only six organisations consulted with their employees about which tests 
to include in the health checks, and only four organisations reported that national initiatives 
or public health guidance had informed their decisions regarding which health tests to 
include. 
GHCs were mostly conducted by occupational health advisors or on-site nurses (n=10, 50%), 
or by health and wellbeing coordinators from external organisations (n=10, 50%). The 
majority of the companies offering health checks provided signposting where appropriate to 
the employee’s general practitioner (GP), with some offering signposting to on-site 
occupational health staff, counselling services, or third sector organisations. Two-thirds of 
the companies reported signposting their employees to online health resources. Test results 
were stored by eight of the 20 companies providing health checks (40%, 1 medium, 7 large). 
Details of the GHCs are presented in Table 3. 
[insert Table 3 about here] 
Of the 98 responding organisations, 68 believed that HIV testing should be available within 
workplace GHCs. However, most of the organisations (n=83, 85%) offered neither HIV 
testing or HIV education. Ten organisations offered only HIV education, two offered only HIV 
testing and three offered both HIV testing and HIV education. Of the five organisations 
providing HIV testing, only one offered HIV testing within a general health check, and the 
remaining four offered HIV testing as part of job-related occupational health surveillance. 
Employer opinions relating to HIV testing in the workplace are summarised in Table 4. 
[insert Table 4 about here] 
All 98 organisation representatives reported at least one perceived benefit of HIV testing in 
the workplace. The most commonly reported benefits of workplace HIV testing were 
increasing employees’ access to health testing (n=74, 75.5%) and knowledge about health 
(n=72, 73.4%), and supporting the promotion of employee health and wellbeing (n=69, 
74.4%). Representatives reported several specific benefits of workplace HIV testing. These 
included the potential for workplace HIV testing to: [a] serve as a mechanism for increased 
employee engagement; [b] demonstrate that the organisation values its employees; [c] 
provide support for corporate social responsibility programmes, and [d] reduce stigma 
around HIV. The most commonly reported barriers to HIV testing in the workplace were: [a] 
not having enough knowledge about HIV and testing (n=65; 66.3%); [b] not having trained 
staff to undertake HIV testing (n=61; 62.2%); and, [c] not knowing how to access HIV testing 
kits (n=62; 63.3%). A minority of company representatives reported that their employees 
would not be interested in GHCs (n=5, 5.1%) or HIV testing (n=10, 10.2%). One quarter of 
company representatives reported that their employees may have privacy concerns related 
to HIV testing at work and a small number of representatives believed there would not be 
enough support from company management for HIV testing at work. However, no reasons 
for these views were provided, and none of these organisational representatives reported 
having consulted with either employees, or other company managers on the provision of 
workplace GHCs, and/or HIV testing. 
Over two-thirds of the company representatives (n=67, 68.4%) were keen to receive further 
guidance on workplace HIV testing and more than half of the participants (n=56, 57.1%) 
would consider HIV testing as a future provision at their organisation. The majority of 
participants would prefer to receive guidance in PDF format (n=65, 97%), with informatics 
and picture support (n=60; 89.6%), and half of them would value case studies of best 
practice (n=33; 49.3%). It was reported that guidance on workplace HIV testing should be 
provided to human resource departments (n=43; 64%), occupational health departments 
(n=18; 26.9%), line managers (n=15; 22.4%), health and wellbeing coordinators (n=10; 
14.9%) or company owners/directors (n=17; 25.4%). All of the organisational 
representatives indicated that guidance should be available in the English language. Only a 
very small number of organisations expressed a desire for guidance in other languages, 
including French, Spanish, Polish and Arabic. 
 
Discussion 
This study is the first to scope the provision of HIV testing in organisations across diverse job 
sectors in the UK. Opt-in HIV testing is currently not provided by almost all employers in this 
study and HIV education and awareness is generally not included in workplace health 
promotion campaigns, although employer views towards HIV testing at work were largely 
positive.  
Despite the strategic importance of employee wellbeing to public health and the economy11-
13, it was notable that less than half of the participating organisations had employee 
wellbeing as part of their organisational strategy, even though all organisational 
representatives (irrespective of the size and type of the organisation) believed that 
promoting health and wellbeing among employees is important. Although workplace health 
initiatives take many forms, most employers did not provide any form of general health 
check for their employees even though GHCs have been shown to be feasible and well-
accepted.17, 33 Those that do provide health tests are more likely to be large organisations 
(rather than SMEs), offering brief tests of usually 15-30 minutes incorporated within a wider 
health and wellbeing programme. Where GHCs are offered, they generally focus on 
assessing risk factors for chronic disease, most commonly including weight, BMI, and blood 
pressure. While these are important checks of lifestyle health behaviours, this finding does 
indicate that there may be a need to support employers to offer check-ups for other 
conditions, including communicable diseases such as HIV or TB. The fact that HIV is not 
currently included may reflect the dominant ‘exceptionalist’ discourse that has surrounded 
the disease where diagnosis has been seen to require specialist skills and support 34. As 
treatment has become widely available and as life expectancies (on treatment) have 
reached near normal levels, there has been a shift to ‘normalise’ HIV by offering testing in a 
range of settings, by a range of people (including lay persons) and within different 
services.35, 36 Our study suggests that the shift towards normalising HIV testing is yet to 
occur within the workplace environment. One method of normalising HIV testing might be 
to offer optional testing within a wider workplace GHC31, and this is consistent with the 
previously established notion that multi- component health interventions are the most 
effective in inducing long term change in worker’s lifestyles.37  
This study identified 3 main barriers for companies in offering workplace HIV testing, which 
are amenable to intervention and support: [a] not having enough knowledge about HIV and 
testing; [b] not having trained staff to undertake HIV testing; and, [c] not knowing how to 
access HIV testing kits. There is a need for guidance to be developed to support employers 
with understanding more about HIV and testing, where to access support for delivery of 
testing, and how to manage employee disclosure of HIV. However, in spite of the perceived 
barriers to workplace HIV testing, there were positive attitudes towards it, since two-thirds 
of respondents wanted more information on workplace HIV testing and more than half 
would consider HIV testing as a future provision.  
Companies offering general health checks made their decisions about the types of tests to 
include based on discussion among management, or through direct approach from external 
organisations. It was notable that the decisions were not generally informed by national 
public health guidance, or by consultation with employees. However, participatory 
approaches to workplace health intervention are known to be beneficial,37 and workplace 
health programmes need to be responsive to public health recommendations, and the 
changing nature of the UK workforce and their needs.  
Migrant workers, for example, present unique challenges for employers. The share of 
foreign-born persons in total employment was estimated to be 16.7% in 2015.38 Economic 
migrants, although often highly skilled, more commonly work in low skilled occupations 
such as process operative work in manufacturing, domestic services, hospitality, elementary 
construction and labouring roles.38 Although often healthy on arrival39 they are affected by a 
combination of social and economic disadvantage, including employment type.40 For a 
variety of reasons, they may be less likely to access NHS services than non-migrants.41 
Workplace health programmes therefore offer a unique opportunity to promote uptake of 
HIV testing, particularly among migrant workers (as a ‘high-risk’ group). There is a clear need 
for further guidance on both HIV testing and workplace health testing more generally, 
particularly for SMEs with fewer resources and/or less well established workplace wellbeing 
programmes, from whom there were more reports of feeling ill-equipped to deliver 
workplace health programmes or support employees disclosing long-term conditions. For all 
organisations considering workplace HIV testing, attention would need to be paid to cultural 
differences in health literacy, and communication about workplace health testing that is 
sensitive to the influence of language, culture, faith and religion on health beliefs and 
practices.  
Limitations 
Due to the nature of data collection through professional online networks, it was not 
possible to determine the number of organisations that received and/or opened the 
invitation message without accessing the survey, or whether the survey was forwarded to 
other organisations. It is therefore not possible to calculate an accurate response rate. 
Further, employers in this study self-selected to complete the online survey and so results 
may not represent the views of companies that did not respond. However, the sample was 
broadly representative of employers more generally as it included micro, small, medium 
(SMEs) and large organisations from the public, private and third sector across 25 job 
sectors.  Responding organisations employed groups at highest risk for HIV and reported 
over 50% male employees, and they employed both mobile and migrant workers from 
diverse regions including those from countries with higher prevalence rates for HIV. 
Conclusions 
Few employers offer general health testing for employees, and workplace HIV testing is 
exceptionally rare, despite broadly positive attitudes towards it. The most common barriers 
to HIV testing are mostly around lack of knowledge about HIV and how to access resources 
for testing, which are amenable to intervention. There is a need to provide evidence-based 
guidance and support for employers around HIV testing in the workplace to increase access 
to HIV testing through the workplace. 
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Figure 1: Number of responding companies per job sector (n=98) 
 
 
 
Table 1: Characteristics of companies and employees 
COMPANY SIZE ALL 
N=98 
MICRO 
N=14 
SMALL 
N=20 
MEDIUM 
N=27 
LARGE 
N=37 
Items  n % n % n % n % n % 
Average age of employees† 
Fisher Exact Test 22.14, df 9, 
p=0.003, Carmer’s V 0.28 
18-30 years 21 21.4 7 50 7 35.0 4 14.8 3 8.1 
31-50 years 32 32.7 2 14.3 9 45.0 6 22.2 15 40.5 
>50 years 2 2.0 1 7.1 0 0.0 0 0.0 1 2.7 
Diverse age range 43 43.9 4 28.6 4 20.0 17 63.0 18 48.6 
Mobile workers 0-10% 49 50 6 42.8 12 60 16 59.2 15 40.5 
11-50% 
31 31.7 3 21.3 4 20 7 25.9 17 45.9 
51-90% 
11 11.2 2 14.2 3 15 2 7.4 4 10.8 
91-100% 
7 7.1 3 21.4 1 5 2 7.4 1 2.7 
  mean SD mean SD mean SD mean SD mean SD 
Gender breakdown (%) (n=95) Female  47.8 25.5 51.4 39.0 48.9 24.3 43.5 21.1 49.2 23.0 
Male  51.7 25.2 48.6 39.0 50.0 24.0 56.1 21.2 50.4 22.5 
Transgender 0.3 1.1 0.0 0.0 0.2 0.4 0.1 0.4 0.8 1.8 
Staffing breakdown (%) 
(n=95) 
Full-time 52.0 29.9 62.7 46.6 52.6 35.4 44.9 21.5 53.1 23.5 
Part-time 23.6 21.2 13.6 29.8 24.1 27.2 30.1 18.1 22.2 12.8 
Others  
24.8 28.2 20.5 37.7 22.9 29.8 27.1 27.6 26 23.7 
† p-value < 0.01, SD standard deviation  
 
Table 2: Workplace Health Checks: company attitudes and provision 
COMPANY SIZE ALL 
N=98 
MICRO 
N=14 
SMALL 
N=20 
MEDIUM 
N=27 
LARGE 
N=37 
Items  n % n % n % n % n % 
Promoting employee health and wellbeing is important 
Fisher Exact Test 2.46, df 3, p=0.49, Carmer’s V 0.14 
Yes 95 96.9 13 92.9 19 95.0 27 100 36 97.3 
No 3 3.1 1 7.1 1 5.0 0 0.0 1 2.7 
Well-equipped to support employee with long term condition† 
Pearson Chi-square 34.85, df 3, p=0.000, Carmer’s V 0.60 
Yes 63 64.3 3 21.4 6 30.0 20 74.1 34 91.9 
No 35 35.7 11 78.6 14 70.0 7 25.9 3 8.1 
Employee health and wellbeing within organisational policy† 
Pearson Chi-square 29.35, df 3, p=0.000, Carmer’s V 0.55 
Yes 41 41.8 2 14.3 3 15.0 8 29.6 28 75.7 
No 57 58.2 12 85.7 17 85.0 19 70.4 9 24.3 
Invite charities in for health and wellbeing awareness-raising† 
Fisher Exact Test 25.36, df 3, p=0.000, Carmer’s V 0.52 
Yes 33 33.7 2 14.3 4 20.0 3 11.1 24 64.6 
No 65 66.3 12 85.7 16 80.0 24 88.9 13 35.1 
Currently offering health check to employees† 
Fisher Exact Test 17.26, df 3, p=0.000, Carmer’s V 0.44 
Yes 22 22.4 1 7.1 1 5.0 3 11.1 17 45.9 
No 76 77.6 13 92.9 19 95.0 24 88.9 20 54.1 
Types of health check offered (n=22) 
Fisher Exact Test 6.51, df 6, p=0.48, 
Carmer’s V 0.30 
           
Occupational screening only 2 9.1 0 0.0 0 0.0 1 33.3 1 5.9 
General health check only 4 18.2 0 0.0 0 0.0 1 33.3 3 17.6 
Both the above 16 72.7 1 100 1 100 1 33.3 13 76.5 
Offered general health checks in the past year†  
Fisher Exact Test 24.38, df 6, p=0.000, Carmer’s V 0.36 
Yes 22 22.4 1 7.1 1 5.0 2 7.4 18 48.6 
Maybe 1 1.0 0 0.0 0 0.0 0 0.0 1 2.7 
No 75 76.5 13 92.9 19 95.0 25 92.6 18 48.6 
Plan to develop general health checks in the future† 
Fisher Exact Test 24.60, df 6, p=0.000, Carmer’s V 0.36 
Yes 12 12.2 1 7.1 0 0.0 2 7.4 9 24.3 
Maybe 33 33.7 1 7.1 6 30.0 7 25.9 19 51.4 
No 53 54.1 12 85.7 14 70.0 18 66.7 9 24.3 
† p-value < 0.01 
 
  
Table 3: Workplace health checks and HIV testing (n=98) 
COMPANY SIZE ALL 
N=20 
MICRO 
N=1 
SMALL 
N=1 
MEDIUM 
N=2 
LARGE 
N=16 
Items n % n % n % n % n % 
General health checks provision           
In the last 6 months 2 10.0 0 0.0 0 0.0 0 0.0 2 12.5 
In the last year 5 25.0 0 0.0 0 0.0 0 0.0 5 31.3 
In the last 2 years 3 15.0 0 0.0 1 100.0 0 0.0 2 12.5 
In the last 5 years 3 15.0 0 0.0 0 0.0 1 50.0 2 12.5 
In the last 5-10 years 3 15.0 1 100.0 0 0.0 1 50.0 1 6.3 
More than 10 years ago 4 20.0 0 0.0 0 0.0 0 0.0 4 25.0 
Components of general health checks           
Weight 17 85.0 1 100.0 1 100.0 2 100.0 14 87.5 
Body mass index 16 80.0 0 0.0 0 0.0 2 100.0 14 87.5 
Resting heart rate 9 45.0 1 100.0 0 0.0 2 100.0 6 37.5 
Blood glucose (diabetes) 11 55.0 1 100.0 1 100.0 1 50.0 8 50.0 
Cholesterol 11 55.0 1 100.0 1 100.0 1 50.0 8 50.0 
Strength test 3 15.0 1 100.0 0 0.0 0 0.0 2 12.5 
Aerobic fitness test 2 10.0 0 0.0 0 0.0 0 0.0 2 12.5 
Bone density 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
HIV testing 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
Hepatitis C 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
Tuberculosis 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
Stress 5 25.0 0 0.0 1 100.0 0 0.0 4 25.0 
Other tests (blood pressure, body/ visceral fat, hearing, eye, skin thickness, 
waist hip ratio, lung function or spirometry) 
9 45.0 1 100.0 1 100.0 2 100.0 7 43.8 
Frequency of health checks           
1-2 occasions per year 13 65.0 0 0.0 0 0.0 2 100.0 11 68.8 
3-4 occasions per year 2 10.0 1 100.0 0 0.0 0 0.0 1 6.3 
5-10 occasions per year 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
More than 10 occasions per year 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
On demand 4 20.0 0 0.0 1 100.0 0 0.0 3 18.8 
Decision-making about health checks            
Consultation with employees 6 30.0 1 100.0 0 0.0 2 100.0 3 18.8 
Discussion within team meetings and agenda 11 55.0 1 100.0 0 0.0 1 50.0 9 56.3 
Availability of tests or training in-house 6 30.0 0 0.0 0 0.0 1 50.0 5 31.3 
Approached by external organisation 13 65.0 1 100.0 1 100.0 1 50.0 10 62.5 
Follow national initiatives or guidance  4 20.0 0 0.0 0 0.0 0 0.0 4 25.0 
Health check delivery           
Internal occupational health advisors / doctor / site nurse 10 50.0 0 0.0 0 0.0 1 50.0 9 56.3 
Internal health and wellbeing coordinators 3 15.0 0 0.0 0 0.0 0 0.0 3 18.8 
Workplace Health Champion (Employees) - Peer to peer 1 5.0 0 0.0 0 0.0 0 0.0 1 6.3 
External occupational health advisors / doctor / nurse 5 25.0 1 100.0 0 0.0 1 50.0 3 18.8 
External health and wellbeing coordinators / organisation 10 50.0 1 100.0 1 100.0 1 50.0 7 43.8 
Follow up options           
No further support or signposting 2 10.0 0 0.0 0 0.0 0 0.0 2 12.5 
Occupational health or on-site nurse 9 45.0 0 0.0 0 0.0 1 50.0 8 50.0 
Health and wellbeing coordinator 2 10.0 0 0.0 0 0.0 1 50.0 1 6.3 
Signposted to GP 19 95.0 1 100.0 1 100.0 2 100.0 15 93.8 
Signposted to hospital services 6 30.0 0 0.0 1 100.0 1 50.0 4 25.0 
Signposted to counselling services 11 55.0 0 0.0 1 100.0 1 50.0 9 56.3 
Signposted to third sector organisations 10 50.0 1 100.0 1 100.0 1 50.0 7 43.8 
Other (HIV consultant, condition specific) 2 10.0 0 0.0 1 100.0 0 10.0 1 6.3 
Signposted to online resources 13 65.0 1 100.0 1 100.0 1 50.0 10 62.5 
 
  
Table 4: Perceptions of the benefits and caveats of offering workplace HIV testing (n=98) 
COMPANY SIZE ALL 
N=98 
MICRO 
N=14 
SMALL 
N=20 
MEDIUM 
N=27 
LARGE 
N=37 
Items n % n % n % n % n % 
Perceived benefits of workplace HIV testing           
Increases access to personal health testing 74 75.5 13 92.9 16 80.0 20 74.1 25 67.6 
Increases knowledge about health 72 73.5 12 85.7 17 85.0 19 70.4 24 64.9 
Promotes employee health and wellbeing 69 70.4 12 85.7 17 85.0 19 70.4 21 56.8 
Helps to keep employees engaged 60 61.2 13 92.9 13 65.0 16 59.3 18 48.6 
Demonstrates that the organisation values its employees 59 60.2 9 64.3 14 70.0 16 59.3 20 45.9 
Supports corporate social responsibility 55 56.1 9 64.3 11 55.0 15 55.6 20 54.1 
Reduces stigma around HIV 55 56.1 6 42.9 14 70.0 14 51.9 21 56.8 
Other benefits 13 13.3 1 7.1 3 15.0 4 14.8 5 13.5 
Perceived caveats to workplace HIV testing           
Don’t know enough about HIV and testing 65 66.3 10 71.4 18 90.0 20 74.1 17 45.9 
Don’t know how to access HIV test kits 62 63.3 9 64.3 15 75.0 20 74.1 18 48.6 
No trained staff to undertake testing 61 62.2 9 64.3 14 70.0 19 70.4 19 51.4 
Not enough time to do this 45 45.9 9 64.3 10 50.0 12 44.4 14 37.8 
Would not be enough support from management 27 27.6 0 0.0 4 20.0 10 37.0 13 35.1 
Employees have privacy concerns 26 26.5 0 0.0 3 15.0 8 29.6 15 40.5 
HIV screening not appropriate in the workplace 21 21.4 1 7.1 1 5.0 6 22.2 13 35.1 
No space to host this 16 16.3 4 28.6 6 30.0 3 11.1 3 8.1 
Other (e.g. company too small, HIV stigma) 13 13.3 2 14.3 4 20.0 2 7.4 5 13.5 
Employees not interested in HIV testing 10 10.2 2 14.3 3 15.0 1 3.7 4 10.8 
No barriers to HIV testing 6 6.1 0 0.0 2 10.0 2 7.4 2 5.4 
Employees not interested in health checks 5 5.1 1 7.1 3 15.0 1 3.7 0 0.0 
 
